Novo Integrated Sciences, Inc. (NVOS)

OTCMKTS · Delayed Price · Currency is USD
0.0035
+0.0004 (12.90%)
At close: Mar 6, 2026
-92.84%
Market Cap 69.06K
Revenue (ttm) 13.29M
Net Income (ttm) -16.17M
Shares Out 19.73M
EPS (ttm) -0.90
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 613
Average Volume 8,450
Open 0.0035
Previous Close 0.0031
Day's Range 0.0035 - 0.0035
52-Week Range 0.0001 - 0.0700
Beta 0.63
RSI 53.93
Earnings Date Dec 18, 2025

About Novo Integrated Sciences

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, ... [Read more]

Sector Healthcare
CEO Robert Mattacchione
Employees 264
Stock Exchange OTCMKTS
Ticker Symbol NVOS
Full Company Profile

Financial Performance

In fiscal year 2024, Novo Integrated Sciences's revenue was $13.29 million, an increase of 5.75% compared to the previous year's $12.57 million. Losses were -$16.17 million, 22.3% more than in 2023.

Financial Statements

News

There is no news available yet.